OBM Genetics

(ISSN 2577-5790)

OBM Genetics is an international Open Access journal published quarterly online by LIDSEN Publishing Inc. It accepts papers addressing basic and medical aspects of genetics and epigenetics and also ethical, legal and social issues. Coverage includes clinical, developmental, diagnostic, evolutionary, genomic, mitochondrial, molecular, oncological, population and reproductive aspects. It publishes research articles, reviews, communications and technical notes, etc. There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.

Archiving: full-text archived in CLOCKSS.

Publication Speed (median values for papers published in 2022): Submission to First Decision: 4 weeks; Submission to Acceptance: 12 weeks; Acceptance to Publication: 13 days (1-2 days of FREE language polishing included)

Current Issue: 2023  Archive: 2022 2021 2020 2019 2018 2017

Special Issue

Pharmacogenomics and Precision Medicine: Unraveling the Future of Personalized Therapy

Submission Deadline: October 31, 2024 (Open) Submit Now

Guest Editor

Ahmad R. Alsayed, PhD, Associate Professor

Therapeutics and Precision Medicine, Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan

Website | E-Mail

Research Interests: microbiome dysbiosis; microbiome health; pharmacogenomics; drug development

About This Topic

Pharmacogenomics, the study of how an individual's genetic makeup influences their response to drugs, is at the forefront of modern medicine's transition towards precision and personalized therapies. Recent advancements in genomic technologies and innovative computational approaches have enabled us to unravel the complex interplay between genetic variations, drug metabolism, and treatment outcomes. This special issue aims to showcase the latest breakthroughs in pharmacogenomics research, emphasizing its pivotal role in shaping the landscape of precision medicine.

We invite researchers and clinicians to contribute their original research, reviews, and perspectives on various dimensions of pharmacogenomics and its applications in precision medicine. Topics of interest include, but are not limited to:

  1. Genomic Variation and Drug Response: Explore the influence of genetic polymorphisms on drug metabolism, efficacy, safety, and adverse reactions across different therapeutic areas. 
  2. Pharmacogenomics in Oncology: Highlight the role of pharmacogenomics in tailoring cancer treatments, optimizing chemotherapy regimens, and predicting drug responses in cancer patients. 
  3. Translational Applications: Discuss the implementation of pharmacogenomics findings in clinical practice, focusing on strategies to bridge the gap between research and real-world patient care. 
  4. Bioinformatics and Data Integration: Present novel bioinformatics tools and integrative approaches for analyzing large-scale genomic and clinical datasets in the context of pharmacogenomics. 
  5. Ethical and Regulatory Considerations: Examine the ethical, legal, and regulatory challenges of integrating pharmacogenomics into clinical decision-making and patient care. 
  6. Pharmacogenomics and Drug Development: Explore how pharmacogenomics influences drug discovery, clinical trial design, and the development of targeted therapies. 
  7. Patient Education and Engagement: Discuss approaches to effectively communicate pharmacogenomics information to patients, empowering them to make informed decisions about their treatment plans.